Basic Information
Basic information for LINC00343-323-11aa-1
Peptide Name LINC00343-323-11aa-1
Genome Position chr13:105764077-105764109[+]
Species Human
Peptide Sequence MRVALNCECSS
Peptide Length 11
Unique No (LINC00343-202-11aa-2,LINC00343-205-11aa,LINC00343-225-11aa,LINC00343-232-11aa,LINC00343-243-11aa,LINC00343-250-11aa,LINC00343-252-11aa-2,LINC00343-253-11aa-1,LINC00343-255-11aa-1,LINC00343-257-11aa-2,LINC00343-258-11aa-3,LINC00343-262-11aa-2,LINC00343-264-11aa-2,LINC00343-265-11aa,LINC00343-270-11aa,LINC00343-291-11aa-2,LINC00343-293-11aa,LINC00343-294-11aa-1,LINC00343-299-11aa,LINC00343-303-11aa-2,LINC00343-306-11aa-2,LINC00343-315-11aa-2,LINC00343-321-11aa,LINC00343-324-11aa,LINC00343-326-11aa-2,LINC00343-328-11aa-1)
Grand Average of Hydropathicity 0.3273
Relative Molecular Mass 1392.57
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000670771;LINC00343-323
Transcript Length 1983
Coding Ability 0.4937
DNA Sequence Corresponding to Peptide ATGAGAGTGGCATTGAACTGTGAATGTTCCTCC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :